Medical Devices
Home » Radioimmunoassay Market

Radioimmunoassay Market

Radioimmunoassay Market: Growth, Future Prospects & Competitive Analysis, 2018-2026
Report Book

Published Date: May 2018
Category: Medical Devices
Report ID: 59174
Report Format: PDF
No of Pages: 120

Rating: Credence Reports

Market Insights

An immunoassay is a bioanalytical method used to detect or measure specific proteins or other substances through their properties as antigens or antibodies. A radioimmunoassay (RIA) is an immunoassay that uses an antigen labeled with a radioisotope and measures the subsequent radioactivity of the antibody component in order to detect the antigen-antibody complex. RIA is gaining noteworthy significance in medical diagnostics owing to its high precision, accuracy, specificity of results, and sensitivity. RIA kits are used to perform in vitro assays and procedures, whereas a radioimmunoassay analyzer is a device used to run immunoassay tests in order to detect the presence and concentration of substances in the samples.

The use of the radioimmunoassay technique in medical research to find small molecules in the blood and in the clinical diagnosis of cancer, autoimmune diseases, infectious diseases, endocrine disorders, and allergic diseases is majorly driving the growth of the radioimmunoassay market. Technological advances in RIA products, coupled with the rising adoption of RIA in clinical laboratories, pharmaceutical industries, and research institutes, are fostering the market’s growing rapidly. Moreover, rapid developments in medical research and increased spending on research and development in the healthcare sector will support market growth in the near future. On the contrary, the presence of alternatives to RIA, such as ELISA (enzyme-linked immunosorbent assay), chemiluminescent immunoassay (CLIA), and immunofluorescence assay (IFA), is anticipated to hinder the market’s growth over the forecast period.

The reagents and kits segment is expected to dominate the market during the forecast period owing to their limited durability and frequent purchase or use. The clinical diagnosis segment is likely to register a lucrative CAGR over the forecast period owing to the rising worldwide prevalence of cancer, autoimmune diseases, infectious diseases, endocrine disorders, and allergic diseases. On the basis of end users, the medical laboratories segment is anticipated to exhibit profitable market growth over the next nine years, which is attributed to the rising demand to perform diagnostic procedures.

Europe is likely to hold a major chunk of the market due to the higher adoption of the radioimmunoassay technique in medical laboratories, pharmaceutical companies, and research institutes, coupled with flourishing pharmaceutical industries in the U.K., Germany, France, Italy, and Spain. Asia Pacific will experience the fastest market growth, owing to a growing geriatric population and rising cancer incidence, as well as propelled demand for RAI in China and India.

The global radioimmunoassay market is segmented on the following basis:

Global Radioimmunoassay Market, by Product, 2016–2026 (US$ Mn)

  • Reagents and Kits
  • Analyzers

Global Radioimmunoassay Market, by Application, 2016–2026 (US$ Mn)

  • Medical Research
  • Clinical Diagnosis

Global Radioimmunoassay Market, by End User, 2016–2026 (US$ Mn)

  • Hospitals
  • Pharmaceutical Companies
  • Academic Research Institutes
  • Medical Laboratories
  • Others

Global Radioimmunoassay Market by Geography (US$ Mn), 2016-2026

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Key players identified in the global radioimmunoassay market include:

  • PerkinElmer Inc.
  • Beckman Coulter, Inc.
  • SA DIAsource ImmunoAssays
  • Euro Diagnostica AB
  • Merck KGaA
  • MP Biomedicals, LLC
  • DiaSorin S.p.A.
  • Berthold Technologies GmbH & Co. KG
  • DRG International, Inc.
  • Stratec Biomedical AG

This report offers the following:

  • comprehensive overview of the global radioimmunoassay market, including the current and future market dynamics
  • Elucidation of each market segment based on product approvals, launches, and current and anticipated market dynamics
  • Company profiles and competitive landscape of market leaders operating in the radioimmunoassay market, comprising key products, operating business areas, financial analysis, and recent strategic developments

Frequently Asked Questions

What is the size of Radioimmunoassay Market?

The market for Radioimmunoassay Market is expected to reach US$ XX Mn by 2026.

What is the Radioimmunoassay Market CAGR?

The Radioimmunoassay Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Radioimmunoassay Market?

The report is forecasted from 2018-2026.

What is the base year considered for Radioimmunoassay Market?

The base year of this report is 2017.

Who are the major players in this market?

PerkinElmer Inc., Beckman Coulter, Inc., SA DIAsource ImmunoAssays, Euro Diagnostica AB, Berthold Technologies GmbH & Co. KG are some of the major players in the global market.

Download Sample Report

Have a question?

Market Research Analyst

Don’t settle for less – trust Ishika to help you find the best solution.

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


+91 8085 89 5002


24/7 Research Support

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN